Press Releases
News
Careers
Contact

Home
About
Leadership
Pipeline
Technology
Investors
Patients
News
Careers
Contact

Recent Posts

Pharmaceutical Manufacturer Q&A: Artiva Allogeneic NK Cell Therapies for Treating Autoimmune Disease
GEN: The Body’s Delta Force: Natural Killer Cells Re-Emerge
The Bio Report Podcast: Turning Natural Killers into Off-the-Shelf Therapies for Autoimmune Disease
In Vivo: Artiva Leverages Unmodified NK Cells To Challenge CAR-T Paradigm
Drug Discovery World: Expanding Access to Cell Therapies for Autoimmune Conditions

Archives

April 2025
March 2025
February 2025
January 2025
November 2024
August 2024
May 2024
April 2024
March 2024
February 2024
December 2023
November 2023

Categories

Artiva In the News

Archives

April 2025
March 2025
February 2025
January 2025
November 2024
August 2024
May 2024
April 2024
March 2024
February 2024
December 2023
November 2023

Category: Advisors

Kenneth Kalunian, M.D.

Jill Buyon, M.D.

Maureen McMahon, M.D.

Brad Rovin, M.D.

Evren Alici, M.D., Ph.D.

Richard Maziarz, M.D.

Peter Flynn, Ph.D.

Thorsten Graef, M.D., Ph.D.

Contact

Privacy Policy
Terms

© Artiva Biotherapeutics, Inc., 2025

Sign up for news updates

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy